---
$id: https://graph.org.ai/products/commodity/51101682
$type: Product
source: UNSPSC
code: "51101682"
title: "Satranidazole"
class: "51101600"
classTitle: "Amebicides and trichomonacides"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Satranidazole

**UNSPSC Code**: 51101682
**Class**: [Amebicides and trichomonacides](Amebicides and trichomonacides.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiprotozoal agent with the molecular formula C8H11N5O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4N7G8A6439, chemically known as 2-imidazolidinone, 1-(1-methyl-5-nitro-1h-imidazol-2-yl)-3-(methylsulfonyl)- but generally known as satranidazole, which bears US NIH Compound Identifier 41841. European Medicines Agency schedules Satranidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10459MIG. The term SATRANIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). SATRANIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule satranidazole under HS 29350090 and SITC 51580. As of Q4 2014, SATRANIDAZOLE remains the US FDA Preferred Term for this commodity. Satranidazole bears US NLM identifiers UMLS ID C0141597 and NCI Concept Code C72155. SMILES: S(=O)(=O)(N1CCN(C1=O)C1N(C([N](=O)O)CN1)C)C.

